NCT07221942 · Interventional trial
Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line Metastatic Urothelial Carcinoma
Overall registry status Recruiting
Phase 2
Conditions Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Unresectable Urothelial Carcinoma
Delaware Valley sites
- Fox Chase Cancer Center - Philadelphia · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory